Figure 7.
Figure 7. Effect of inhibition of thrombin, fibrin(ogen), or platelet function upon endotoxin mortality. Effects of thrombin inhibition (A) or lack of fibrinogen (B) or platelets (C) on endotoxin mortality. Wild-type C57BL/6 female mice treated with hirudin (5 mg/kg intraperitoneally), antiplatelet serum, and/or FTY720 (0.1 mg/kg intraperitoneally) and Fib–/– or Nf-E2–/– (both 50% C57BL/6, 50% 129SVJ) mice and appropriate vehicle- or nonimmune serum-injected or littermate controls were injected intraperitoneally with high- or low-dose LPS and monitored for 26 or 72 hours as indicated. P values as determined by log-rank test are shown when less than .05. For littermate studies, P value refers to comparison between knockouts and wild types.

Effect of inhibition of thrombin, fibrin(ogen), or platelet function upon endotoxin mortality. Effects of thrombin inhibition (A) or lack of fibrinogen (B) or platelets (C) on endotoxin mortality. Wild-type C57BL/6 female mice treated with hirudin (5 mg/kg intraperitoneally), antiplatelet serum, and/or FTY720 (0.1 mg/kg intraperitoneally) and Fib/ or Nf-E2/ (both 50% C57BL/6, 50% 129SVJ) mice and appropriate vehicle- or nonimmune serum-injected or littermate controls were injected intraperitoneally with high- or low-dose LPS and monitored for 26 or 72 hours as indicated. P values as determined by log-rank test are shown when less than .05. For littermate studies, P value refers to comparison between knockouts and wild types.

Close Modal

or Create an Account

Close Modal
Close Modal